Abstract
Stem cell-based therapies represent a promising therapy for myocardial infarct. Pre-clinical and clinical tests performed in the last 10 years indicate that several types of stem cells and their progenies reduce infarct size and improve cardiac contractile function. The mechanism is dependent on the type of cell and involves a combination of several factors, such as: (i) the formation of new blood vessels, (ii) the release of pro-survival, pro-angiogenic and antiinflammatory factors (paracrine effect), and (iii) the functional contribution of cardiomyocytes. With the exception of cardiac progenitor cells and pluripotent stem cells (human embryonic stem cells and inducible pluripotent stem cells) that have the unquestioned ability to give rise to cardiomyocytes, the other stem cells, including bone marrow stem cells and fetal stem cells, have none or very limited capacity to differentiate into contractile cells. For both cases, it is of the utmost importance to develop strategies to promote cell survival and in vivo engraftment as well as to unravel the therapeutic mechanism of stem cells. This review focuses on the recent developments of stem cells and on the use of biomaterials for efficient stem cell delivery and tracking.
Keywords: Stem cells, heart regeneration, biomaterials, nanoparticles and magnetic resonance imaging (MRI).
Cardiovascular & Hematological Disorders-Drug Targets
Title: Stem Cell-Based Therapies for Heart Regeneration: What did the Bench Teach Us?
Volume: 10 Issue: 3
Author(s): L. Ferreira, D.C.S. Pedroso, H. Vazao and R.S.M. Gomes
Affiliation:
Keywords: Stem cells, heart regeneration, biomaterials, nanoparticles and magnetic resonance imaging (MRI).
Abstract: Stem cell-based therapies represent a promising therapy for myocardial infarct. Pre-clinical and clinical tests performed in the last 10 years indicate that several types of stem cells and their progenies reduce infarct size and improve cardiac contractile function. The mechanism is dependent on the type of cell and involves a combination of several factors, such as: (i) the formation of new blood vessels, (ii) the release of pro-survival, pro-angiogenic and antiinflammatory factors (paracrine effect), and (iii) the functional contribution of cardiomyocytes. With the exception of cardiac progenitor cells and pluripotent stem cells (human embryonic stem cells and inducible pluripotent stem cells) that have the unquestioned ability to give rise to cardiomyocytes, the other stem cells, including bone marrow stem cells and fetal stem cells, have none or very limited capacity to differentiate into contractile cells. For both cases, it is of the utmost importance to develop strategies to promote cell survival and in vivo engraftment as well as to unravel the therapeutic mechanism of stem cells. This review focuses on the recent developments of stem cells and on the use of biomaterials for efficient stem cell delivery and tracking.
Export Options
About this article
Cite this article as:
Ferreira L., Pedroso D.C.S., Vazao H. and Gomes R.S.M., Stem Cell-Based Therapies for Heart Regeneration: What did the Bench Teach Us?, Cardiovascular & Hematological Disorders-Drug Targets 2010; 10 (3) . https://dx.doi.org/10.2174/1871529X11006030173
DOI https://dx.doi.org/10.2174/1871529X11006030173 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Evaluation of Anti-cancer Activity of Stilbene and Methoxydibenzo[b,f] oxepin Derivatives
Current Cancer Drug Targets Diagnostic Value of the Early Heart-to-Mediastinum Count Ratio in Cardiac 123I-mIBG Imaging for Parkinson's Disease
Current Radiopharmaceuticals Novel Colchicine Derivatives and their Anti-cancer Activity
Current Topics in Medicinal Chemistry Clinical Approach to Diabetic Cardiomyopathy: A Review of Human Studies
Current Medicinal Chemistry How to Investigate the Vascular Changes in Resistant Hypertension
Current Hypertension Reviews Oral IIa and Xa Inhibitors for Prevention of Stroke in Atrial Fibrillation: Clinical Studies and Regulatory Considerations
Current Clinical Pharmacology Therapeutic Opportunities for Trophic Factors in Brain Inflammation
Current Pharmaceutical Analysis Connexin43 and Myocardial Ischemia-Reperfusion Injury
Cardiovascular & Hematological Disorders-Drug Targets Antifungal Activity of Plant Secondary Metabolites on <i>Candida albicans</i>: An Updated Review
Current Molecular Pharmacology Impact of Postprandial Remnant Lipoproteins on Coronary Artery Disease
Vascular Disease Prevention (Discontinued) The Effect of Bisoprolol on Premature Ventricular Complex in Vietnamese Patients with Hypertension and Left Ventricular Hypertrophy
Current Hypertension Reviews The Complications of Bariatric Surgery Patients with Type 2 Diabetes in the World: A Systematic Review and Meta-Analysis
Current Diabetes Reviews Targeting of Low-Molecular Weight Drugs to Mammalian Mitochondria
Drug Design Reviews - Online (Discontinued) Expeditious and Green Synthesis of 2,3-Dihydroquinazolin-4(1H)-ones Catalyzed by Nano-MgO
Letters in Organic Chemistry Phenylbutyric Acid Protects Against Spatial Memory Deficits in a Model of Repeated Electroconvulsive Therapy
Current Neurovascular Research Critical Review of the Simple Theoretical Models in Dynamic Imaging: Up-Slope Method and Graphical Analysis
Current Radiopharmaceuticals Loss of Medial Septum Cholinergic Neurons in THY-Tau22 Mouse Model: What Links with tau Pathology?
Current Alzheimer Research Bivalirudin in Patients with Coronary Artery Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Pathophysiological Role of Proteasome-Dependent Proteolytic Pathway in Endothelin-1-Related Cardiovascular Diseases
Current Vascular Pharmacology Increasing Neurogenesis with Fluoxetine, Simvastatin and Ascorbic Acid Leads to Functional Recovery in Ischemic Stroke
Recent Patents on Drug Delivery & Formulation